Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Boosting mitochondrial health can reverse protein clumping in aging and Alzheimer's

Boosting mitochondrial health can reverse protein clumping in aging and Alzheimer's

New therapy shows greater weight loss in mice by targeting brain's appetite center

New therapy shows greater weight loss in mice by targeting brain's appetite center

Repurposing human-approved drugs for prion disease treatment

Repurposing human-approved drugs for prion disease treatment

Unraveling the mystery of Alzheimer's resilience at molecular level

Unraveling the mystery of Alzheimer's resilience at molecular level

Study identifies a new biomarker for Alzheimer's disease in asymptomatic stages

Study identifies a new biomarker for Alzheimer's disease in asymptomatic stages

Study reveals CNTN4 gene's role in neuronal development and Alzheimer's disease pathogenesis

Study reveals CNTN4 gene's role in neuronal development and Alzheimer's disease pathogenesis

Sleep and anesthesia hinder brain toxin clearance, study reveals

Sleep and anesthesia hinder brain toxin clearance, study reveals

New technique reveals brain cells age at different rates

New technique reveals brain cells age at different rates

Racial and ethnic disparities in Alzheimer's diagnosis and CNS drug prescription

Racial and ethnic disparities in Alzheimer's diagnosis and CNS drug prescription

Study sheds light on the crucial role of glutamate tRNA fragments in brain aging and Alzheimer's disease

Study sheds light on the crucial role of glutamate tRNA fragments in brain aging and Alzheimer's disease

Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

Ensemble deep learning models enhance early diagnosis of Alzheimer's disease using neuroimaging data

Ensemble deep learning models enhance early diagnosis of Alzheimer's disease using neuroimaging data

Superagers' brains resist age-related decline, study finds

Superagers' brains resist age-related decline, study finds

Youth-onset diabetes linked to higher Alzheimer's risk

Youth-onset diabetes linked to higher Alzheimer's risk

FAU researchers receive grants to tackle Alzheimer's disease

FAU researchers receive grants to tackle Alzheimer's disease

Mathematical microscope sheds light on efficient memory formation even during sleep

Mathematical microscope sheds light on efficient memory formation even during sleep

APOE4 gene linked to early onset Alzheimer's, target for therapeutic intervention

APOE4 gene linked to early onset Alzheimer's, target for therapeutic intervention

Study identifies APOE4 homozygotes as high-risk group for Alzheimer's disease

Study identifies APOE4 homozygotes as high-risk group for Alzheimer's disease

Global research offers insights about health burden disparities between genders

Global research offers insights about health burden disparities between genders

Rapamycin shows promise in slowing Alzheimer's disease progression linked to seizures

Rapamycin shows promise in slowing Alzheimer's disease progression linked to seizures

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.